World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
84
Citations
38083
World Ranking
14859
National Ranking
7514

E. Michael Lewiecki publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where E. Michael Lewiecki sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 357 publications — 29th percentile

29% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

E. Michael Lewiecki D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where E. Michael Lewiecki sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 84 D-Index — 27th percentile

27% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

E. Michael Lewiecki is affiliated with the University of New Mexico in the United States. Their research work focuses primarily on the field of Medicine, with a significant emphasis on Orthopedics and Sports Medicine, Oncology, Surgery, Molecular Biology, and Nephrology. This multidisciplinary approach underscores a broad interest in medical conditions related to bone health and metabolic disorders.

The main topics of Lewiecki's research include bone health and osteoporosis research, bone health and treatments, hip and femur fractures, bone and joint diseases, bone metabolism and diseases, parathyroid disorders and treatments, and vitamin D research studies.

Lewiecki has contributed to a number of recent publications, including the following:

  • "The clinician's guide to prevention and treatment of osteoporosis" (2022), published in Osteoporosis International
  • "American Association of Clinical Endocrinologists/American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis-2020 Update" (2020), published in Endocrine Practice
  • "Global Epidemiology of Hip Fractures: Secular Trends in Incidence Rate, Post-Fracture Treatment, and All-Cause Mortality" (2023), published in the Journal of Bone and Mineral Research
  • "American Association of Clinical Endocrinologists/American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis-2020 Update Executive Summary" (2020), published in Endocrine Practice
  • "American Association of Clinical Endocrinologists/American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis-2020 Update" (2021), published in Endocrine Practice

Lewiecki frequently publishes in a variety of scientific venues, with notable publication counts in these journals:

  • Osteoporosis International (18 publications)
  • Journal of Clinical Densitometry (14 publications)
  • Journal of Bone and Mineral Research (9 publications)
  • Journal of the Endocrine Society (7 publications)
  • Endocrine Practice (5 publications)

Collaborations form a significant part of Lewiecki's research activity. The most frequent co-authors include:

  • Serge Ferrari (14 co-authored publications)
  • Neil Binkley (13 co-authored publications)
  • Maria Luisa Brandi (11 co-authored publications)
  • Aliya Khan (11 co-authored publications)
  • Gordon Guyatt (11 co-authored publications)

The scope of Lewiecki's work reflects a detailed engagement with bone-related conditions, including osteoporosis prevention and treatment protocols, epidemiological trends in hip fractures, and clinical guidelines addressing postmenopausal osteoporosis. Their multidisciplinary subfields emphasize both clinical practice and molecular aspects of bone metabolism and disease.

Best Publications

  • Clinician’s Guide to Prevention and Treatment of Osteoporosis

    F. Cosman;S. J. de Beur;M. S. LeBoff;E. M. Lewiecki

  • Denosumab in postmenopausal women with low bone mineral density

    Michael R. McClung;E. Michael Lewiecki;Stanley B. Cohen;Michael A. Bolognese

  • Romosozumab Treatment in Postmenopausal Women with Osteoporosis.

    F. Cosman;D. B. Crittenden;J. D. Adachi;N. Binkley

  • American Association of Clinical Endocrinologists and American College of Endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis — 2016

    Pauline M. Camacho;Steven M. Petak;Neil Binkley;Dima L. Diab

  • Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long-term continued, discontinued, and restarting of therapy: a randomized blinded phase 2 clinical trial.

    Paul D. Miller;Michael A. Bolognese;E. Michael Lewiecki;Michael R. McClung

  • International Society for Clinical Densitometry 2007 Adult and Pediatric Official Positions

    E. Michael Lewiecki;Catherine M. Gordon;Sanford Baim;Mary B. Leonard

  • Clinical use of quantitative computed tomography and peripheral quantitative computed tomography in the management of osteoporosis in adults: the 2007 ISCD Official Positions.

    Klaus Engelke;Judith E. Adams;Gabriele Armbrecht;Peter Augat

  • Interpretation and use of FRAX in clinical practice

    J. A. Kanis;D. Hans;C. Cooper;C. Cooper;S. Baim

  • Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop.

    Richard Eastell;A. Arnold;M. L. Brandi;E. M. Brown

  • Bisphosphonate Therapy for Osteoporosis: Benefits, Risks, and Drug Holiday

    Michael McClung;Steven T. Harris;Paul D. Miller;Douglas C. Bauer

  • Official positions of the International Society for Clinical Densitometry.

    Edward S. Leib;E. Michael Lewiecki;Neil Binkley;Ronald C. Hamdy

  • Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus.

    A A Khan;D A Hanley;R. Rizzoli;J Bollerslev

  • Quantitative ultrasound in the management of osteoporosis: the 2007 ISCD Official Positions.

    Marc-Antoine Krieg;Reinhart Barkmann;Stefano Gonnelli;Alison Stewart

  • Monthly oral ibandronate therapy in postmenopausal osteoporosis: 1-year results from the MOBILE study.

    Paul D. Miller;Michael R. McClung;Liviu Macovei;Jacob A. Stakkestad

  • Official Positions of the International Society for Clinical Densitometry

    E. Michael Lewiecki;Nelson B. Watts;Michael R. McClung;Steven M. Petak

  • Two‐Year Treatment With Denosumab (AMG 162) in a Randomized Phase 2 Study of Postmenopausal Women With Low BMD

    E Michael Lewiecki;Paul D Miller;Michael R McClung;Stanley B Cohen

  • Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop.

    Shonni J. Silverberg;Bart L. Clarke;Munro Peacock;Francisco Bandeira

  • Early Changes in Biochemical Markers of Bone Formation Predict BMD Response to Teriparatide in Postmenopausal Women With Osteoporosis

    Peiqi Chen;Julie H Satterwhite;Angelo A Licata;E Michael Lewiecki

  • Executive Summary of the 2019 ISCD Position Development Conference on Monitoring Treatment, DXA Cross-calibration and Least Significant Change, Spinal Cord Injury, Peri-prosthetic and Orthopedic Bone Health, Transgender Medicine, and Pediatrics

    Christopher R. Shuhart;Swan Sim Yeap;Paul A. Anderson;Lawrence G. Jankowski

  • Precision Assessment and Radiation Safety for Dual-Energy X-Ray Absorptiometry: Position Paper of the International Society for Clinical Densitometry

    Sanford Baim;Charles R. Wilson;E. Michael Lewiecki;Marjorie M. Luckey

Frequent Co-Authors

Paul D. Miller
Paul D. Miller University of Colorado Anschutz Medical Campus
John P. Bilezikian
John P. Bilezikian Columbia University
Neil Binkley
Neil Binkley University of Wisconsin–Madison
Michael R. McClung
Michael R. McClung Australian Catholic University
Robert R. Recker
Robert R. Recker Creighton University
David A. Hanley
David A. Hanley University of Calgary
William D. Leslie
William D. Leslie University of Manitoba
Peter R. Ebeling
Peter R. Ebeling Monash University
Didier Hans
Didier Hans University of Lausanne
Jacques P. Brown
Jacques P. Brown Université Laval

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

The journey to a medical career in the USA extends beyond traditional medical school routes. Many healthcare fields now offer flexible online learning options that can help students build rewarding paths in medicine-related professions.

For nursing professionals aiming for advanced clinical or leadership positions, best online bsn to dnp programs make it possible to achieve a Doctor of Nursing Practice remotely and affordably. Similarly, those interested in pharmaceuticals can pursue pharmd online programs, which are designed for working professionals seeking a terminal pharmacy degree.

For a non-clinical healthcare career, earning a certification through rhia certification programs online can open doors in health information management and IT. Additionally, medical billing and coding certification online programs provide flexible, fast pathways to enter administrative and data-driven healthcare roles.

These online degree and certification options make it easier for students and professionals to access diverse opportunities and grow their healthcare careers from anywhere.

Best Scientists Citing E. Michael Lewiecki

Trending Scientists

Recently Published Articles